Ioannis A. Christopoulos
Patra, ESYE23 26500, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Intravenous Immunoglobulin in Acute Exacerbations of Fibrotic Interstitial Lung Diseases: A Retrospective, Real-World Study.
Journal: Medicina (Kaunas, Lithuania)
Published: July 30, 2025
Geographical Inequalities and Comorbidities in the Timely Diagnosis of NSCLC: A Real-Life Retrospective Study from a Tertiary Hospital in Western Greece.
Journal: Cancers
Published: July 27, 2025
The bacterial lysate OM-85 reduces exacerbations and oral corticosteroid use in frequently exacerbating patients with T2-High asthma: The OMREXA real-world evidence study.
Journal: Respiratory medicine
Published: May 09, 2025
The bacterial lysate OM-85 Reduces Exacerbations and Oral Corticosteroid Use in Frequently Exacerbating Patients with T2-High Asthma: The OMREXA Real-World Evidence Study.
Journal: Respiratory medicine
Published: May 09, 2025
Real-World Evidence of Administration of Biologic Agents in Patients with Severe Asthma: An Analysis of the Respiratory Department of University Hospital of Patras Asthma Registry.
Journal: Journal of clinical medicine
Published: March 11, 2025
Complete Blood Cell Count Parameters Predict Mortality in Patients with Hypersensitivity Pneumonitis.
Journal: Diagnostics (Basel, Switzerland)
Published: March 07, 2025
Biologic Agents in Idiopathic Hypereosinophilic Syndrome.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 06, 2025
Oral Bacterial Lysate OM-85 Prevents Respiratory Tract Infections in Asthma: The OMRIA RWE Study.
Journal: Journal of asthma and allergy
Published: January 22, 2025
Clinical features and outcomes of patients with myositis associated-interstitial lung disease.
Journal: Frontiers in medicine
Published: November 11, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026